Universiteit Leiden

nl en

Sjoerd van der Burg

Professor Immunotherapy of solid tumours, in particular of the kidney

Name
Prof.dr. S.H. van der Burg
Telephone
+31 71 526 1180
E-mail
s.h.van_der_burg@lumc.nl

Sjoerd van der Burg is full professor in the immunotherapy of solid tumors with emphasis on immunomonitoring at the University of Paris. he is Head of the laboratory of Experimental Oncology of the departments of Medical Oncology and Ophthalmology at Leiden University Medical Center. He is also Leader of the group of Experimental Cancer Immunology and Therapy, Member of the permanent Science Committee (VCW) of the LUMC and Member of the Steering Committee of “Cancer Pathogenesis and Therapy.

More information about Sjoerd van der Burg

Sjoerd van der Burg is full professor in the immunotherapy of solid tumors with emphasis on immunomonitoring at the University of Paris. he is Head of the laboratory of Experimental Oncology of the departments of Medical Oncology and Ophthalmology at Leiden University Medical Center. He is also    Leader of the group of Experimental Cancer Immunology and Therapy, Member of the permanent Science Committee (VCW) of the LUMC and Member of the Steering Committee of “Cancer Pathogenesis and Therapy.

Immunotherapy

Immunotherapy in its various forms has more recently been added as the fourth pillar for the treatment of solid tumours in addition to surgery, radiation therapy, and chemotherapy. Immunotherapy based on the infusion, the activation and/or the unblocking of tumour-specific T cells had clinical success in patients with yet unmet clinical need.  The aim of my chair fits well with cluster questions 85 and 96 of the Dutch National Research Agenda and  is to implement immunotherapy as treatment modality for patients with solid tumors by focusing on the exploration of key factors in host-tumor interactions that determine successes and failures in immune control of cancer via fundamental, translational and clinical studies using animal models, patient cohorts and clinical trials. 

Academic career

Van der Burg received his PhD on April, 1 1998 for his thesis on Identification and evaluation of cytotoxic T-cell epitopes in HIV-1 and tumour-associated proteins, from the Leiden University.

In 2003 he was appointed as staff member (LUMC) and assistant professor (Leiden University) at the department of Immunohematology of the LUMC.

In 2006 he was appointed as associate professor and  head of the laboratory of the department of Clinical Oncology, and leader of the group of Experimental Cancer Immunology and Therapy. In 2010 he was promoted to full professor following which he gave his public speech (oratie) with the title “Op zoek naar een éénarmige immunoloog”on  May 9, 2011.

Prizes and honourable appointments

In 2004, Van der Burg received the Marie Parijs Prize for innovative research on health topics. Furthermore, in that year he was endowed with the VIDI prize, a large grant from the Netherlands Organisation for Scientific Research for top researchers in the Netherlands.

In 2008, he received an educational prize for best teaching module Molecular Biology & Oncology (BS-3).

Since 2010, is Van der Burg appointed as part time Advisor for the immunomonitoring of spontaneous and immune therapy induced immune responses at the Dutch Cancer Institute, Amsterdam, The Netherlands.

Professor Immunotherapy of solid tumours, in particular of the kidney

  • Faculteit Geneeskunde
  • Divisie 4
  • Klinische Oncologie

Work address

LUMC Main Building
Albinusdreef 2
2333 ZA Leiden
Room number K1-P

Contact

  • GSK, Rixensart, België Consultant
  • DC prime, the Netherlands Scientific advisory board
  • ISA pharmaceuticals, the Netherlands Strategic advisory board

This website uses cookies. More information